We Have A Strategic Vision for Global Aging

Taking On Longevity with Market Innovation

We develop initiatives that focus on meeting the challenges of worldwide aging with groundbreaking market solutions and progressive public policies.

Through our white papers, roundtables, webinars, presentations to third parties, and other communications materials, we are leading the global aging dialogue and providing public education designed to enable healthier and more active aging.

2024 AMR Preparedness Index Progress Report

Released in February 2024, in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) in September, the 2024 AMR Preparedness Index Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

Read Now

The Role of Healthy Aging and Adult Immunization in Achieving Fiscal Sustainability and Economic Growth Across the APEC Region

This GCOA report demonstrates the economic imperative for APEC economies to invest in healthy aging broadly, and adult immunization in particular, amid rapid population aging. The APEC region is at the leading edge of the global demographic shift, and programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.

Read Now

Healthy Aging in Practice: How Age-Friendly Cities & Communities Can Contribute to an Age-Friendly World

In June 2023, GCOA released its report, "Healthy Aging in Practice: How Age-Friendly Cities & Communities Can Contribute to an Age-Friendly World," following a roundtable held in New York City with Age Friendly Ireland, along with the United Nations Department of Social and Economic Affairs (UNDESA), the New York City Department for the Aging, and other stakeholders.

Read Now

The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis

In April 2023, the Global Coalition on Aging (GCOA) convened a private workshop of experts and officials from Japan, Sweden, the United Kingdom, Italy and the United States to discuss how pull incentives within Japan and around the G7 could reinvigorate antibiotic innovation.

Read Now

Silver Economy Forum 2023

2024

2024 AMR Preparedness Index Progress Report

2024

How to Better Support Older Adults and Their Families for Shared Decision-Making About Cancer Care

2024

State of Financial Preparedness in a Diverse America

2024

Report on Life Course Immunization and Integrated Care

2024

Report on Adult Vaccination in Five Global Cities

2023

A State Analysis of the Legal Implications of an Alzheimer’s or Other Dementia Diagnosis

2023

Report on Adult Immunization and Economic Growth in the APEC Region

2023

Best Practices for Employee Benefits in Different Life Stages

2023

Partner Perspectives on Global Aging

The emergence of the Global Coalition on Aging is tremendously exciting, and I am particularly encouraged that it brings together diverse companies to work together on this pressing issue. It is unique in its philosophy that the best solution is to enable us all to remain engaged and productive through healthy and active aging.

Dr. John Beard
Irene Diamond Professor of Productive Aging (in Health Policy Management, Epidemiology and in the Robert N. Butler Columbia Aging Center),
Columbia University Mailman School of Public Health
Former Director of Ageing and Life Course,
World Health Organization

Improving Bone Health in the UN Decade of Healthy Ageing

2023

Policy Principles to Improve Innovation & Equity for Healthy Aging

2023

Report on Global Adult Vaccination Trends

2023

Report on Young Adults and Workplace Wellness

2023

Healthy Aging in Practice: How Age-Friendly Cities & Communities Can Contribute to an Age-Friendly World

2023

Report on Young Adults and Retirement

2023

Report on Menopause in the Workplace

2023

Report on the Post-Pandemic Workplace and Workforce

2023

The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis

2023

Claim your seat at the table